IP Library Granted Patent US 7,625,351
Granted Patent B2
US 7,625,351 · App. 10/938,693 · Granted Dec 1, 2009

System, method and apparatus for purifying biological fluids such as blood and constituents thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,625,351
App. No.
10/938,693
Granted
Dec 1, 2009
Kind
B2
Abstract

Provided herein is an innovative hemoperfusion system and method including a thermal-fused broad-spectrum biocidal iodinated interactive polymer for the treatment of biological contaminants in body fluids. In one exemplary embodiment, the system and method utilizes a Triosyn® thermal fused broad-spectrum iodinated interactive polymer, included in a hemoperfusion column, for devitalizing high levels of cell-free microorganisms in whole blood and biological fluids in relation with the characterization of blood cells viability and function post-treatment.

Claims (17)

1. A hemoperfusion filtration system, comprising:

a) a centrifuge for whole blood to provide a red blood cell concentrate;

b) a dilution unit for diluting said red blood cell concentrate;

c) a chamber containing a demand disinfectant iodinated resin and a plurality of diffusers for maximizing the contact of said diluted red blood cell concentrate and said iodinated resin; and

d) a pump for moving said diluted red blood cell concentrate through said chamber at a selected flow rate.

2. The hemoperfusion filtration system of claim 1 , wherein said chamber is composed of a filter capsule, inlet end cap and a first mesh and a second mesh, wherein said inlet end cap is located close to said first mesh.

3. The hemoperfusion filtration system of claim 2 , wherein said filter capsule comprises the plurality of diffusers present between said first mesh and said second mesh.

4. The hemoperfusion filtration system of claim 1 , further comprising: c′)a centrifuge for removing residual plasma that is present in said diluted red blood cell concentrate after passage through said chamber; and f′) a filter for removing leukocytes.

5. The hemoperfusion filtration system of claim 1 , further comprising: e′″) a transfusion unit for transfusing said diluted red blood cell concentration after passage of said column into a human.

6. The system as in claim 1 , wherein said centrifuge centrifuges said blood at 37° C. at 3200 RPM for five minutes.

7. The system as in claim 1 , wherein said dilution unit dilutes said red blood cell concentrate using saline or other acceptable physiological fluid at 37° C.

8. A portable hemoperfusion filtration system, comprising:

a) a means for removing plasma from whole blood to provide a red blood cell concentrate;

b) a dilution device for diluting said red blood cell concentrate;

c) a chamber containing a demand disinfectant, said demand disinfectant being an iodinated resin contained in said column; and

d) a pump for moving said diluted red blood cell concentrate a blood constitute through said chamber column at a selected flow rate.

9. A hemoperfusion filtration chamber comprising a demand disinfectant iodinated resin and a plurality of hydrodynamnic diffusers, wherein the diffusers function to increase the contact efficacy between the iodinated resin and bacteria in blood that is passed through said chamber.

Assignments (15)
SECURITY AGREEMENT Recorded Feb 28, 2013
From: TIOMED INNOVATIONS CORP.
To: FONDACTION, LE FONDS DE DEVELOPPMENT DE LA CONFEDERATION DES SYNDICATES NATIONAUX POUR LA COOPERATION ET L'EMPLOI
Reel/Frame 029900/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2012
From: SAFE LIFE / TRIOSYN CORP.
To: TRIOMED INNOVATIONS CORP.
Reel/Frame 028861/0446 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2011
From: SOFNOV SOCIETE FINANCIERE D'INNOVATION INC.; BUSINESS DEVELOPMENT BANK OF CANADA; SOCIETE INNOVATECH DU GRAND MONTREAL; MACLEOD, RAY; BERGERON, GILES; SL VENTURES; BRB SPORTS UNLIMITED; MARTIN, JACQUES; DONLAN, DAVID A.; O'BRIEN, JOSEPH W.; O'BRIEN, SHIRLEY; HARNELL, WILLIAM; HARNELL, TERESA; CAPOSELLA, CARMINE; JAGOE, HARVEY
To: TRIOSYN CORP.
Reel/Frame 026362/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2011
From: MESSIER, PIERRE J.
To: SAFELIFE/TRIOSYN CORP.
Reel/Frame 026348/0688 →
RELEASE Recorded Dec 16, 2010
From: SILICON VALLEY BANK
To: TRIOSYN HOLDING INC.
Reel/Frame 025641/0732 →
RELEASE Recorded Dec 16, 2010
From: SILICON VALLEY BANK
To: TRIOSYN CORP.
Reel/Frame 025641/0727 →
CORRECTIVE ASSIGNMENT TO CORRECT THE IDENTIFICATION OF ASSIGNEE AND ASSIGNOR PREVIOUSLY RECORDED ON REEL 023749 FRAME 0127. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Jan 13, 2010
From: VANTAGEPOINT CDP ASSOCIATES, L.P.; VANTAGEPOINT CDP ASSOCIATES, L.L.C.
To: TRIOSYN CORP.; SAFE LIFE CORP.
Reel/Frame 023793/0389 →
RELEASE OF SECUITY INTEREST Recorded Jan 7, 2010
From: TRIOSYN CORP.; SAFE LIFE CORP.
To: VANTAGEPOINT CDP ASSOCIATES, L.P.; VANTAGEPOINT CDP ASSOCIATES, L.L.C.
Reel/Frame 023749/0127 →
SECURITY AGREEMENT Recorded Jun 19, 2009
From: TRIOSYN HOLDING INC.
To: SILICON VALLEY BANK
Reel/Frame 022846/0719 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Apr 8, 2009
From: TRIOSYN CORP.; SAFE LIFE CORP.
To: VANTAGEPOINT CDP ASSOCIATES, L.P.; VANTAGEPOINT CDP ASSOCIATES, L.L.C.
Reel/Frame 022521/0423 →
SECURITY AGREEMENT Recorded Jan 8, 2009
From: TRIOSYN CORP.
To: SILICON VALLEY BANK
Reel/Frame 022078/0275 →
RELEASE OF SECURITY INTEREST AND COLLATERAL Recorded Jun 27, 2007
From: VANTAGEPOINTE CDP PARTNER, L.P.
To: TRIOSYN CORP.; HEMO-BIOTECH INC., TRIOSYN HOLDING INC., TRIOSYN RESEARCH INC.
Reel/Frame 019511/0644 →
RELEASE OF SECURITY INTEREST AND COLLATERAL Recorded Jun 27, 2007
From: VANTAGEPOINT CDP PARTNERS, L.P.
To: TRIOSYN HOLDING INC.
Reel/Frame 019511/0619 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Jun 15, 2006
From: TRIOSYN CORP.; HENO-BIOTECH INC.; TRIOSYN HOLDING INC.; TRIOSYN RESEARCH INC. (F/K/A HYDRO-BIO TECH INC.)
To: VANTAGEPOINT CDP PARTNERS, L.P.
Reel/Frame 017783/0587 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Jun 15, 2006
From: TRIOSYN HOLDING INC.
To: VANTAGE POINT CDP PARTNERS, L.P.
Reel/Frame 017783/0778 →